Your account is not claimed yet. You can sign up with ORCID to claim your account.

James W Janetka

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 7

Top Venues

Journal of medicinal chemistry

Scientific reports

Science (New York, N.Y.)

MedChemComm

ProteXase Therapeutics, Inc.

University of Wisconsin Madison (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

ProteXase Therapeutics, Inc. Jan 20o 2017

United States

Co-founder, Board of Directors

Education History

University of Wisconsin Madison

United States

PHD :: Chemistry/Daniel Rich

Publications

Vishnu C Damalanka, Jorine J L P Voss, Matthew W Mahoney, Tina Primeau, Shunqiang Li, Lidija Klampfer, James W Janetka
Macrocyclic Inhibitors of HGF-Activating Serine Proteases Overcome Resistance to Receptor Tyrosine Kinase Inhibitors and Block Lung Cancer Progression. Journal of medicinal chemistry 64 (24) (2021)
James W Janetka, Allen T Hopper, Ziping Yang, Jennifer Barks, Mary Savari Dhason, Qiuling Wang, L David Sibley
Optimizing Pyrazolopyrimidine Inhibitors of Calcium Dependent Protein Kinase 1 for Treatment of Acute and Chronic Toxoplasmosis. Journal of medicinal chemistry 63 (11) (2020)
Vishnu C Damalanka, Scott A Wildman, James W Janetka
Piperidine carbamate peptidomimetic inhibitors of the serine proteases HGFA, matriptase and hepsin. MedChemComm 10 (9) (2019)
Rahul Tyagi, Mostafa A Elfawal, Scott A Wildman, Jon Helander, Christina A Bulman, Judy Sakanari, Bruce A Rosa, Paul J Brindley, James W Janetka, Raffi V Aroian, Makedonka Mitreva
Identification of small molecule enzyme inhibitors as broad-spectrum anthelmintics. Scientific reports 9 (1) (2019)
Amarendar Reddy Maddirala, Roger Klein, Jerome S Pinkner, Vasilios Kalas, Scott J Hultgren, James W Janetka
Biphenyl Gal and GalNAc FmlH Lectin Antagonists of Uropathogenic E. coli (UPEC): Optimization through Iterative Rational Drug Design. Journal of medicinal chemistry 62 (2) (2019)
Vishnu C Damalanka, Zhenfu Han, Partha Karmakar, Anthony J O'Donoghue, Florencia La Greca, Tommy Kim, Shishir M Pant, Jonathan Helander, Juha Klefström, Charles S Craik, James W Janetka
Discovery of Selective Matriptase and Hepsin Serine Protease Inhibitors: Useful Chemical Tools for Cancer Cell Biology. Journal of medicinal chemistry 62 (2) (2019)
Agostinho G Rocha, Antonietta Franco, Andrzej M Krezel, Jeanne M Rumsey, Justin M Alberti, William C Knight, Nikolaos Biris, Emmanouil Zacharioudakis, James W Janetka, Robert H Baloh, Richard N Kitsis, Daria-Mochly Rosen, R Reid Townsend, Evripidis Gavathiotis, Gerald W Dorn
MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. Science (New York, N.Y.) 360 (6386) (2018)

James W Janetka.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

James W Janetka